The heterogeneity of viral bronchiolitis: A lack of universal consensus definitions

  title={The heterogeneity of viral bronchiolitis: A lack of universal consensus definitions},
  author={David G Hancock and Billie Charles-Britton and Dani-Louise Dixon and Kevin D. Forsyth},
  journal={Pediatric Pulmonology},
  pages={1234 - 1240}
Viral bronchiolitis is one of the most common hospital presentations in infancy and as such represents a major healthcare burden worldwide. However despite this, there are currently no effective targeted therapies nor can those infants at highest risk for developing severe disease or subsequent respiratory morbidity be predicted on initial hospital presentation. Current definitions of bronchiolitis in the published literature vary significantly in terms of the age range at presentation… 


Bronchiolitis clinics and medical treatment.

The most controversial points in the management of bronchiolitis are discussed according to six evidence-based guidelines, six clinical practice guidelines and five consensus-based reviews.

Criteria heterogeneity in the diagnosis of acute bronchiolitis in Spain☆☆☆

Overview of prevention and management of acute bronchiolitis due to respiratory syncytial virus

Despite advances in preventative treatments, adherence to evidence-based guidelines provides the best prospect for successful reduction in morbidity and mortality.

Time to Say Goodbye to Bronchiolitis, Viral Wheeze, Reactive Airways Disease, Wheeze Bronchitis and All That

A proposed simplified approach to the nomenclature used to categorize virus associated LRTIs is presented based on an understanding of the underlying pathological processes and how these contribute to the physical signs.

Maybe this is just asthma

  • B. Kuzik
  • Medicine
    Pediatric pulmonology
  • 2017
The apparent lack of bronchodilator response in bronchiolitis, and hence the dogmatic approach that this is not asthma, should remain open for debate.

Rhinovirus Type in Severe Bronchiolitis and the Development of Asthma



Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants

Pharmacological prophylaxis with palivizumab for RSV bronchiolitis is indicated in specific categories of children at risk during the epidemic period, and may correlate with an increased incidence of recurrent wheezing in pre-schooled children and with asthma at school age.

Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age.

Groups at high risk for severe disease are described and guidelines for admission to hospital are presented, and evidence for the efficacy of various therapies is discussed and recommendations are made for management.

A clustering approach to identify severe bronchiolitis profiles in children

Several distinct clinical profiles (phenotypes) were identified by a clustering approach in two multicentre studies of children hospitalised for bronchiolitis, having important implications for future research on the aetiology, management and long-term outcomes of bronchiolaitis.

Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5

The aim of this study was to evaluate the outcome at third to fifth year after admission for hMPV‐bronchiolitis and to compare it with children admitted for respiratory syncytial virus (RSV), with children without lower respiratory disease in the first 2 years of life.

Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches

Large cohort studies of bronchiolitis with comprehensive clinical characterization and system-wide profiling of the ‘-omics’ data should enhance the ability to molecularly understand these phenotypes and lead to more targeted and personalized approaches to bron chiolitis treatment.

Bronchiolitis: Age and Previous Wheezing Episodes Are Linked to Viral Etiology and Atopic Characteristics

In children with bronchiolitis, 2 clinical factors, age and number of previous wheezing episodes, are linked to inflammatory (atopy-related factors) and virologic risk factors of asthma (rhinovirus-associated disease).

Acute viral bronchiolitis: Physician perspectives on definition and clinically important outcomes

This work assessed how paediatricians and general practitioners perceived definition and clinically important outcomes in bronchiolitis and the heterogeneous choice of outcome measures in current clinical trials.